Natixis Advisors
ANIP icon

Natixis Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Natixis Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,807
Closed -$1.45M – 1594
2025
Q3 		$1.45M Sell
15,807
-3,095
-16% -$252K ﹤0.01% 1206
2025
Q2 		$1.23M Buy
18,902
+166
+0.9% +$10.8K ﹤0.01% 1236
2025
Q1 		$1.25M Buy
18,736
+135
+0.7% +$8.06K ﹤0.01% 1217
2024
Q4 		$1.03M Buy
18,601
+417
+2% +$23.9K ﹤0.01% 1297
2024
Q3 		$1.08M Buy
18,184
+6,545
+56% +$399K ﹤0.01% 1270
2024
Q2 		$741K Buy
+11,639
New +$756K ﹤0.01% 1341

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return